Targeted News Service

UTHealth Houston-developed Cancer Therapy Platform Takes Major Step Toward Clinical Translation
April 15, 2026

HOUSTON, Texas, April 15 -- The University of Texas Health Science Center at Houston issued the following news:

* * *

UTHealth Houston-developed cancer therapy platform takes major step toward clinical translation

By Jeannette Sanchez

CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by researchers at UTHealth Houston, is taking a major step toward clinical translation after being . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form